BRPI0507718A - Pyrazoline derivatives useful for cancer treatment - Google Patents
Pyrazoline derivatives useful for cancer treatmentInfo
- Publication number
- BRPI0507718A BRPI0507718A BRPI0507718-4A BRPI0507718A BRPI0507718A BR PI0507718 A BRPI0507718 A BR PI0507718A BR PI0507718 A BRPI0507718 A BR PI0507718A BR PI0507718 A BRPI0507718 A BR PI0507718A
- Authority
- BR
- Brazil
- Prior art keywords
- cancer
- treatment
- compounds
- cancer treatment
- derivatives useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
DERIVADOS DE PIRAZOLINA úTEIS PARA O TRATAMENTO DE CáNCER A presente invenção relaciona-se a novos compostos de pirazolina substituídos, composições farmacêuticas contendo tais compostos e o uso destes compostos para o tratamento de câncer, particularmente para o tratamento de câncer cerebral, câncer nos ossos, cãncer labial, câncer da boca, câncer esofageal, câncer de estomago, câncer de fígado, câncer de bexiga, cãncer de pâncreas, câncer de óvario, cârcer cervical, cãncer de pulmão, câncer de mama, cãncer de pele, especialmente para o tratamento de cãncer de cólon e/ou câncer de intestino e/ou câncer de próstata.Useful PIRAZOLINE DERIVATIVES FOR CANCER TREATMENT The present invention relates to novel substituted pyrazoline compounds, pharmaceutical compositions containing such compounds and the use of these compounds for the treatment of cancer, particularly for the treatment of brain cancer, bone cancer, lip cancer, mouth cancer, esophageal cancer, stomach cancer, liver cancer, bladder cancer, pancreatic cancer, ovary cancer, cervical cancer, lung cancer, breast cancer, skin cancer, especially for the treatment of colon cancer and / or bowel cancer and / or prostate cancer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200400362A ES2238923B1 (en) | 2004-02-16 | 2004-02-16 | NEW SUBSTITUTED PIRAZOLINIC DERIVATIVES. |
US10/804,695 US20050182119A1 (en) | 2004-02-16 | 2004-03-19 | Substituted pyrazoline derivatives |
PCT/EP2005/001656 WO2005077910A1 (en) | 2004-02-16 | 2005-02-16 | Pyrazoline derivatives useful for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0507718A true BRPI0507718A (en) | 2007-07-03 |
Family
ID=34863166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0507718-4A BRPI0507718A (en) | 2004-02-16 | 2005-02-16 | Pyrazoline derivatives useful for cancer treatment |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1718618A1 (en) |
JP (1) | JP2007522180A (en) |
KR (1) | KR20070044799A (en) |
AU (1) | AU2005212833A1 (en) |
BR (1) | BRPI0507718A (en) |
CA (1) | CA2556478A1 (en) |
NO (1) | NO20064185L (en) |
RU (1) | RU2006133150A (en) |
WO (1) | WO2005077910A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008308473A (en) * | 2007-06-18 | 2008-12-25 | Japan Health Science Foundation | Cancer-treating agent |
CN101735150B (en) * | 2009-12-16 | 2011-12-28 | 南京大学 | Thiourea derivatives containing pyrromonazole ring, preparation method and use thereof |
CN101759695B (en) * | 2009-12-30 | 2011-09-14 | 南京大学 | Thiazole derivative containing pyrazole ring and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146851A0 (en) * | 1999-06-16 | 2002-07-25 | Univ Temple | 1- (4-sulfamylaryl)- 3- substituted -5-ayl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
ES2174757B1 (en) * | 2001-04-06 | 2003-11-01 | Esteve Labor Dr | EMPLOYMENT OF FIRAZOLIN DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION AND / OR TREATMENT OF CELLULAR PROLIFERATIVE DISEASES. |
-
2005
- 2005-02-16 EP EP05707483A patent/EP1718618A1/en not_active Withdrawn
- 2005-02-16 AU AU2005212833A patent/AU2005212833A1/en not_active Abandoned
- 2005-02-16 JP JP2006552580A patent/JP2007522180A/en active Pending
- 2005-02-16 BR BRPI0507718-4A patent/BRPI0507718A/en not_active IP Right Cessation
- 2005-02-16 KR KR1020067018161A patent/KR20070044799A/en not_active Application Discontinuation
- 2005-02-16 RU RU2006133150/04A patent/RU2006133150A/en unknown
- 2005-02-16 WO PCT/EP2005/001656 patent/WO2005077910A1/en active Application Filing
- 2005-02-16 CA CA002556478A patent/CA2556478A1/en not_active Abandoned
-
2006
- 2006-09-15 NO NO20064185A patent/NO20064185L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2006133150A (en) | 2008-04-10 |
AU2005212833A1 (en) | 2005-08-25 |
CA2556478A1 (en) | 2005-08-25 |
KR20070044799A (en) | 2007-04-30 |
NO20064185L (en) | 2006-11-13 |
JP2007522180A (en) | 2007-08-09 |
EP1718618A1 (en) | 2006-11-08 |
WO2005077910A1 (en) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008008430A3 (en) | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases | |
EA201690265A3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED ACYLANILIDES | |
NO20055894L (en) | Methods and compositions for the treatment of amyloid-related diseases | |
IL229136A0 (en) | Mek inhibitors and methods of their use | |
ZA200701661B (en) | Isoindoline compounds and methods of making and using the same | |
ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
TW200716606A (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
PL1853602T3 (en) | Chemical compounds | |
SI1853588T1 (en) | Chemical compounds | |
EP1765391A4 (en) | Bacterial compositions for the treatment of cancer | |
IL147271A0 (en) | Compounds that bind her2 | |
TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
EP1937280A4 (en) | Compositions and methods for the diagnosis and therapy of bcl2-associated cancers | |
PL1809288T3 (en) | Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases | |
WO2002057261A3 (en) | Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase | |
IL177645A0 (en) | Phospholipid analogs for diagnosis and treatment of cancer | |
HK1147695A1 (en) | Pharmaceutical solid state forms | |
TW200628473A (en) | Novel heterocycles | |
MX2009003981A (en) | Calcium receptor modulating agents. | |
MX2010003269A (en) | Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase. | |
IL200410A0 (en) | Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer | |
WO2008020269A3 (en) | A method of treating tumors with azaxanthones | |
BRPI0507718A (en) | Pyrazoline derivatives useful for cancer treatment | |
GB2473579A (en) | Stat3 and TYK2 as drug targets for neurodegenerative diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 4A, 5A E 6A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011. |